Upcoming Webinar | Digital Pathology in the New Normal: Leveraging HALO to Investigate a Global Pandemic
.
WEBINAR ANNOUNCEMENT
Digital Pathology in the New Normal: Leveraging HALO® to Investigate a Global Pandemic
8:00 PST | 11:00 EST | 16:00 GMT
As the world was shutting down in the face of the COVID-19 pandemic, digital pathology was thrust to the forefront as a vital option for not only completing ongoing projects, but more importantly for understanding COVID-19 itself. Characterizing the mechanisms by which the novel coronavirus attacks the human body and how the immune system responds to the virus are critical for predicting disease outcomes, creating targeted vaccine candidates and identifying new treatments. Researchers around the world utilized the HALO® suite of products to share rare digital pathology slides, collect quantitative pathological data from translational models, characterize gene expression associated with immune response, and integrate transcriptional data with tissue-based immunoprofiling.
This workshop will present some insight on how HALO has been used by researchers at three different global institutions to study and characterize COVID-19.
PRESENTATIONS:
Using Digital Image Analysis to Characterize Primate Models of COVID-19
Robert Blair
Assistant Professor
Department of Pathology and Laboratory Medicine, Tulane University School of Medicine
Research Pathologist
Division of Comparative Pathology, Tulane National Primate Research Center
The importance of contextual spatial information provided by digital image analysis in SARS-CoV-2 research
Linda Nieman, PhD
Senior Scientist
Massachusetts General Hospital
Understanding COVID-19 lung disease – an integrated digital and molecular pathology perspective
Prof. Dr. med. Viktor Koelzer
Attending Pathologist
Institute of Pathology and Molecular Pathology, University Hospital Zürich
Assistant Professor and Lead
Digital Pathology, University of Zürich
Honorary Senior Clinical Researcher
Department of Oncology, University of Oxford
Moderator:
Adam Smith
Director of Life Science Applications
Indica Labs, Inc.
